Prognostic Modeling in Diffuse Large B-Cell Lymphoma in the Era of Immunochemotherapy: Where Do We Go From Here?

Cancer - United States
doi 10.1002/cncr.30740
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Where Do We Go From Here?

MRS Bulletin
Materials ScienceTheoretical ChemistryCondensed Matter PhysicsPhysical
1986English

Where Do We Go From Here?

The Philosophers' Magazine
2002English

Where Do We Go From Here?

1989English

Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2006English

Calibration Research: Where Do We Go From Here?

Frontiers in Psychology
Psychology
2012English

Photodynamic Therapy: Where Do We Go From Here?

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2003English

The Top Five in Oncology: Where Do We Go From Here?

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2012English

Audit in General Practice: Where Do We Go From Here?

Quality and Safety in Health Care
1993English

Psychiatric Inpatient Care: Where Do We Go From Here?

Epidemiology and Psychiatric Sciences
Mental HealthEpidemiologyPublic HealthEnvironmentalPsychiatryOccupational Health
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy